# Title

 Food and Drugs. PART 830â€”UNIQUE DEVICE IDENTIFICATION


# ID

 CFR-2018-title21-vol8.Pt. 830


# Structured Analysis Summary

| Type        | Values                                                                                                                                                                                                                                                                                                        |
|:------------|:--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Constraints | ['before', 'within', 'prior to', 'more than', 'no later than', 'after', 'at least']                                                                                                                                                                                                                           |
| Duration    | ['9.0 month', '7.0 year', '30.0 day', '6.0 month', '60.0 day', '10.0 day', '3.0 year']                                                                                                                                                                                                                        |
| Condition   | ['until', 'unless', 'where', 'subject to', 'when', 'if']                                                                                                                                                                                                                                                      |
| Entities    | ['United States', 'Labeler', 'Use', 'Universal', 'Certain', 'Small', 'Application', 'Automatic', 'Rockville, MD', 'New York, NY', 'Eligibility', 'Food', 'United Statesnor', 'Unique', 'Finished', 'Human', 'Label', 'Specification', 'Device', 'Switzerland', 'Rm', 'Research', 'Expiration', 'Information'] |
| Date        | ['2006-03-01', '2018-12-31', '2008-07-15', '2007-06-15', '1991-12-15']                                                                                                                                                                                                                                        |


# Structured Analysis With Context

 


## Constraints

| Constraints   | Context                                                                                                                            |
|:--------------|:-----------------------------------------------------------------------------------------------------------------------------------|
| within        | are intended to have uniform characteristics and quality within  specified limits.                                                 |
| within        | of the device: (i) The lot or batch within which a device was manufactured; (ii) The serial                                        |
| within        | devices that have specifications, performance, size, and composition, within  limits set by the labeler.                           |
| at least      | this section, of its intent to seek renewal. at least                                                                              |
| before        | procedures and schedule: (1) At least 9 months before the date of expiration of its accreditation, an                              |
| at least      | in accordance with paragraph (b)(2) of this section. at least                                                                      |
| before        | (3) At least 6 months  before the date of expiration of its accreditation, an                                                      |
| at least      | address given in paragraph (a)(1) of this section at least 9 months before the expiration of the issuing                           |
| before        | (a)(1) of this section at least 9 months before the expiration of the issuing agency's term of                                     |
| prior to      | plans for allowing continued use of UDIs issued prior to  the expiration of the current term of accreditation.                     |
| within        | application and will request correction of those deficiencies within  60 days.                                                     |
| within        | application and will request correction of those deficiencies within  60 days.                                                     |
| within        | the deficiencies are not resolved to FDA's satisfaction within the specified time period, the application for accreditation        |
| before        | reach a final decision on a renewal application before the expiration of an issuing agency's current accreditation,                |
| before        | an issuing agency decides to relinquish its accreditation before expiration of the current term of accreditation, it               |
| at least      | address provided in paragraph (a)(1) of this section, at least  9 months before relinquishing its accreditation.                   |
| before        | an issuing agency decides to relinquish its accreditation before expiration of the current term of accreditation, it               |
| before        | by FDA, or relinquishes its accreditation and duties before expiration of the current term of accreditation, shall                 |
| after         | accreditation of an issuing agency if FDA finds, after providing the issuing agency with notice and opportunity                    |
| more than     | (9) If the device is available in  more than one size, the size of the particular version                                          |
| within        | under &#167;&#8201;830.340 that the labeler wishes to submit, within the time permitted by &#167;&#8201;830.330, addressed to: UDI |
| no later than | submit to FDA the information required by &#167;&#8201;830.310 no later than the date the label of the device must                 |
| no later than | The updated information must be submitted  no later than the date a device is first labeled with                                   |
| within        | a device, the updated information must be submitted within  10 business days of the change.                                        |
| at least      | change on the FDA Web site at http://www.fda.gov/udi/ at least  60 days before making the change.                                  |
| before        | Web site at http://www.fda.gov/udi/ at least 60 days before  making the change.                                                    |
| within        | satisfactory explanation of why the information is correct within  30 days of receipt of FDA's notification.                       |
| within        | the labeler does not respond to FDA's notification within 30 days of receipt, or if FDA determines,                                |


## Duration

| Duration   | Context                                                                                                                                                                                                                                                                                                                                                                                      |
|:-----------|:---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 9.0 month  | An accredited issuing agency that intends to continue to serve as an issuing agency beyond its current term shall apply to FDA for renewal or notify FDA of its plans not to apply for renewal in accordance with the following procedures and schedule:                                                                                                                                     |
|            |               (1) At least 9 months before the date of expiration of its accreditation, an issuing agency shall inform FDA, at the address given in paragraph (a)(1) of this section, of its intent to seek renewal.                                                                                                                                                                         |
| 6.0 month  | (3) At least 6 months before the date of expiration of its accreditation, an issuing agency shall furnish to FDA, at the email address we provide, a copy of a renewal application containing the information, materials, and supporting documentation requested by FDA in accordance with paragraph (b)(2) of this section.                                                                 |
| 9.0 month  | (4) Any issuing agency that does not plan to renew its accreditation shall so notify FDA at the address given in paragraph (a)(1) of this section at least 9 months before the expiration of the issuing agency's term of accreditation and shall include a description of its plans for allowing continued use of UDIs issued prior to the expiration of the current term of accreditation. |
| 60.0 day   | (2) Within 60 days of receipt of an application for accreditation, FDA will notify the applicant of any deficiencies in its application and will request correction of those deficiencies within 60 days.                                                                                                                                                                                    |
| 60.0 day   | (2) Within 60 days of receipt of an application for accreditation, FDA will notify the applicant of any deficiencies in its application and will request correction of those deficiencies within 60 days.                                                                                                                                                                                    |
| 9.0 month  | If an issuing agency decides to relinquish its accreditation before expiration of the current term of accreditation, it shall submit a letter of such intent to FDA, at the address provided in paragraph (a)(1) of this section, at least 9 months before relinquishing its accreditation.                                                                                                  |
| 3.0 year   | The initial term of accreditation for an issuing agency shall be for a period of 3 years.                                                                                                                                                                                                                                                                                                    |
| 7.0 year   | An issuing agency's term of accreditation may be periodically renewed for a period of 7 years.                                                                                                                                                                                                                                                                                               |
| 10.0 day   | If the information does not appear on the label of a device, the updated information must be submitted within 10 business days of the change.                                                                                                                                                                                                                                                |
| 60.0 day   | We will announce any change on the FDA Web site at http://www.fda.gov/udi/ at least 60 days before making the change.                                                                                                                                                                                                                                                                        |
| 30.0 day   | The labeler must provide corrected information or provide a satisfactory explanation of why the information is correct within 30 days of receipt of FDA's notification.                                                                                                                                                                                                                      |
| 30.0 day   | (b) If the labeler does not respond to FDA's notification within 30 days of receipt, or if FDA determines, at any time, that any information in the GUDID is incorrect or could be misleading, we may delete or correct the information.                                                                                                                                                     |
| 3.0 year   | These records must be retained for 3 years from the date the labeler ceases to market the version or model.                                                                                                                                                                                                                                                                                  |


## Condition

| Condition   | Context                                                                                                                        |
|:------------|:-------------------------------------------------------------------------------------------------------------------------------|
| when        | that identifies one or more of the following when included on the label of the device: (i)                                     |
| until       | may continue to use a previously issued UDI until such time as &#167;&#8201;830.50 requires you to assign                      |
| if          | may accredit an organization as an issuing agency, if the system it will operate: (1) Will employ                              |
| when        | review and decisionmaking process the applicant will apply when determining whether a particular labeler may use the           |
| if          | compatible with FDA data systems; (vi) Fee schedules, if any, together with an explanation of any fee                          |
| if          | this section, and we will require less information if experience shows that we need only a subset                              |
| if          | The applicant may request an extension  if it needs additional time to correct deficiencies in                                 |
| if          | under which a denied application may be resubmitted. if                                                                        |
| if          | FDA reaches a final decision on the application. if                                                                            |
| until       | current accreditation, the approval will be deemed extended until  FDA reaches a final decision on the application.            |
| if          | or revoke the accreditation of an issuing agency if FDA finds, after providing the issuing agency with                         |
| where       | (a) During any period  where there is no accredited issuing agency, FDA will                                                   |
| if          | (b) If FDA determines that a sign if icant number of small businesses would be substantially                                   |
| if          | in its discretion, act as an issuing agency if we determine it is necessary for us to                                          |
| if          | in its discretion, act as an issuing agency if we determine it is appropriate for us to                                        |
| if          | may end our services as an issuing agency if we determine that the conditions that prompted us                                 |
| if          | labeler may continue to use a device ident if ier assigned under FDA's unique device ident                                     |
| until       | identifier assigned under FDA's unique device identification system until such time as &#167;&#8201;830.50 requires the use of |
| subject to  | Devices  subject to  device identification data submission requirements.                                                       |
| when        | or while the device is implanted in patient. when                                                                              |
| if          | (1) The device ident if ier portion of the UDI assigned to the                                                                 |
| if          | (1) The device ident if ier portion of the UDI assigned to the                                                                 |
| if          | (1) The device ident if ier portion of the UDI assigned to the                                                                 |
| if          | the device; (10) The type of production ident if iers that appear on the label of the                                          |
| unless      | format that we can process, review, and archive, unless the labeler has obtained a waiver from electronic                      |
| if          | a waiver from electronic submission of UDI data. if                                                                            |
| where       | (2) If the establishment  where the labeler is located has obtained a waiver                                                   |
| where       | (GUDID) other than that specified by &#167;&#8201;830.310, except where FDA acts to permit the submission of specified         |
| if          | information submitted to the Global Unique Device Ident if ication Database (GUDID) appears to be incorrect or                 |
| if          | the labeler does not respond to FDA's not if ication within 30 days of receipt, or                                             |
| if          | the labeler does not respond to FDA's not if ication within 30 days of receipt, or                                             |


## Entities

| Entities         | Context                                                                                                                       |
|:-----------------|:------------------------------------------------------------------------------------------------------------------------------|
| Food             | Food  and Drugs.                                                                                                              |
| Automatic        | Automatic identification and data capture (AIDC) means any technology                                                         |
| Research         | Director of the Center for Biologics Evaluation and Research , depending on which Center has been assigned                    |
| Device           | Device package means a package that contains a fixed                                                                          |
| Expiration       | Expiration date means the date by which the label                                                                             |
| Finished         | Finished device means any device or accessory to any                                                                          |
| Human            | Human cell, tissue, or cellular or tissue-based product (HCT/P)                                                               |
| Label            | Label has the meaning set forth in section 201(k)                                                                             |
| Labeler          | Labeler means: (1) Any person who causes a label                                                                              |
| Small            | Small business means a medical device manufacturer with 500                                                                   |
| Specification    | Specification means any requirement with which a device must                                                                  |
| Unique           | Unique device identifier (UDI) means an identifier that adequately                                                            |
| Universal        | Universal product code (UPC) means the product identifier used                                                                |
| United States    | identify an item sold at retail in the United States .                                                                        |
| Certain          | (a)  Certain material is incorporated by reference into this part                                                             |
| Rockville, MD    | 1061,  Rockville, MD 20852, 301-827-6860, and is available from the source                                                    |
| New York, NY     | Service Department, 25 West 43rd St., 4th floor, New York, NY 10036, phone: 212-642-4980, and may be ordered online           |
| Switzerland      | la Voie-Creuse, Case postale 56, CH-1211 Geneva 20, Switzerland , phone (dialing from the United States): 011-41-22-749-0111, |
| United States    | CH-1211 Geneva 20, Switzerland, phone (dialing from the United States ): 011-41-22-749-0111, and may be ordered online at     |
| Information      | (1) ISO/IEC 646:1991(E),  Information technology&#8212;ISO 7-bit coded character set for information interchange              |
| Information      | (1) ISO/IEC 646:1991(E),  Information technology&#8212;ISO 7-bit coded character set for information interchange              |
| Information      | (1) ISO/IEC 646:1991(E),  Information technology&#8212;ISO 7-bit coded character set for information interchange              |
| Information      | (1) ISO/IEC 646:1991(E),  Information technology&#8212;ISO 7-bit coded character set for information interchange              |
| Use              | Use  and discontinuation of a device identifier.                                                                              |
| Application      | Application  for accreditation as an issuing agency.                                                                          |
| Rm               | 66,  Rm .                                                                                                                     |
| Eligibility      | Eligibility  for use of FDA as an issuing agency.                                                                             |
| United Statesnor | that operates the system used by the labeler. United Statesnor                                                                |
| United States    | a device that is neither manufactured in the United States  nor in interstate commerce in the                                 |
| Rm               | 66,  Rm .                                                                                                                     |
| Rm               | 66,  Rm .                                                                                                                     |


## Date

| Date       | Context                                                                                                                                                                                                                            |
|:-----------|:-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 1991-12-15 | (1) ISO/IEC 646:1991(E), Information technology&#8212;ISO 7-bit coded character set for information interchange (third edition; December 15, 1991), into &#167;&#167;&#8201;830.20(c) and 830.100(b);                              |
|            |               (2) ISO/IEC 15459-2:2006(E), Information technology&#8212;Unique identifiers&#8212;Part 2: Registration procedures (second edition; March 1, 2006), into &#167;&#167;&#8201;830.20(b) and 830.100(b);                |
|            |               (3) ISO/IEC 15459-4:2008(E), Information technology&#8212;Unique identifiers&#8212;Part 4: Individual items (second edition; July 15, 2008), into &#167;&#167;&#8201;830.20(b) and 830.100(b);                       |
|            |               (4) ISO/IEC 15459-6:2007(E), Information technology&#8212;Unique identifiers&#8212;Part 6: Unique identifier for product groupings (first edition; June 15, 2007), into &#167;&#167;&#8201;830.20(b) and 830.100(b). |
| 2006-03-01 | (1) ISO/IEC 646:1991(E), Information technology&#8212;ISO 7-bit coded character set for information interchange (third edition; December 15, 1991), into &#167;&#167;&#8201;830.20(c) and 830.100(b);                              |
|            |               (2) ISO/IEC 15459-2:2006(E), Information technology&#8212;Unique identifiers&#8212;Part 2: Registration procedures (second edition; March 1, 2006), into &#167;&#167;&#8201;830.20(b) and 830.100(b);                |
|            |               (3) ISO/IEC 15459-4:2008(E), Information technology&#8212;Unique identifiers&#8212;Part 4: Individual items (second edition; July 15, 2008), into &#167;&#167;&#8201;830.20(b) and 830.100(b);                       |
|            |               (4) ISO/IEC 15459-6:2007(E), Information technology&#8212;Unique identifiers&#8212;Part 6: Unique identifier for product groupings (first edition; June 15, 2007), into &#167;&#167;&#8201;830.20(b) and 830.100(b). |
| 2008-07-15 | (1) ISO/IEC 646:1991(E), Information technology&#8212;ISO 7-bit coded character set for information interchange (third edition; December 15, 1991), into &#167;&#167;&#8201;830.20(c) and 830.100(b);                              |
|            |               (2) ISO/IEC 15459-2:2006(E), Information technology&#8212;Unique identifiers&#8212;Part 2: Registration procedures (second edition; March 1, 2006), into &#167;&#167;&#8201;830.20(b) and 830.100(b);                |
|            |               (3) ISO/IEC 15459-4:2008(E), Information technology&#8212;Unique identifiers&#8212;Part 4: Individual items (second edition; July 15, 2008), into &#167;&#167;&#8201;830.20(b) and 830.100(b);                       |
|            |               (4) ISO/IEC 15459-6:2007(E), Information technology&#8212;Unique identifiers&#8212;Part 6: Unique identifier for product groupings (first edition; June 15, 2007), into &#167;&#167;&#8201;830.20(b) and 830.100(b). |
| 2007-06-15 | (1) ISO/IEC 646:1991(E), Information technology&#8212;ISO 7-bit coded character set for information interchange (third edition; December 15, 1991), into &#167;&#167;&#8201;830.20(c) and 830.100(b);                              |
|            |               (2) ISO/IEC 15459-2:2006(E), Information technology&#8212;Unique identifiers&#8212;Part 2: Registration procedures (second edition; March 1, 2006), into &#167;&#167;&#8201;830.20(b) and 830.100(b);                |
|            |               (3) ISO/IEC 15459-4:2008(E), Information technology&#8212;Unique identifiers&#8212;Part 4: Individual items (second edition; July 15, 2008), into &#167;&#167;&#8201;830.20(b) and 830.100(b);                       |
|            |               (4) ISO/IEC 15459-6:2007(E), Information technology&#8212;Unique identifiers&#8212;Part 6: Unique identifier for product groupings (first edition; June 15, 2007), into &#167;&#167;&#8201;830.20(b) and 830.100(b). |
| 2018-12-31 | To maintain its accreditation, an issuing agency must:                                                                                                                                                                             |
|            |               (a) Operate a system for assignment of unique device identifiers (UDIs) that meets the requirements of &#167;&#8201;830.20;                                                                                          |
|            |               (b) Make available information concerning its system for the assignment of UDIs;                                                                                                                                     |
|            |               (c) Maintain a list of labelers that use its system for the assignment of UDIs and provide FDA a copy of such list in electronic form by December 31 of each year;                                                   |
|            |               (d) Upon request, provide FDA with information concerning a labeler that is employing the issuing agency's system for assignment of UDIs; and                                                                        |
|            |               (e) Remain in compliance with the eligibility and accreditation criteria set forth in &#167;&#8201;830.100.                                                                                                          |


